Global Peptide Therapeutics market will reach 37400 million US$ by the end of 2025
Published Date: 2018/12/19
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 7.7%. The major factors that are driving the growth of this market are the rising prevalence of metabolic disorders and the increasing pool of cancer patients. The technological advancements, resulting in a significant reduction in the production cost of peptide drugs, is also boosting this market remarkably. In 2017, global revenue of Peptide Therapeutics is nearly 28.5 billion USD; the actual production is about 150 million units.
The classification of Peptide Therapeutics includes Injection, Oral and other, and the proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.
Peptide Therapeutics is widely sales for Cancer, Metabolic Disorders, Central Nervous System and Others. The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.
The global Peptide Therapeutics market is valued at 28500 million US$ in 2017 and will reach 37400 million US$ by the end of 2025, growing at a CAGR of 3.5% during 2018-2025.
Click to view the full report: https://www.qyresearch.com/index/detail/124410/global-peptide-therapeutics-market
Marketing: sales@qyresearchglobal.com
Media Contact: press@qyresearch.com
评论
发表评论